EVOK

Evoke Pharma, Inc.

0.56 USD
+0.02 (+2.98%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Evoke Pharma, Inc. stock is up 19.15% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 63.64% of the previous 10 June’s closed higher than May.

About Evoke Pharma, Inc.

Evoke Pharma, Inc. is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers.